Ravi Retnakaran

15.9k total citations · 3 hit papers
272 papers, 11.7k citations indexed

About

Ravi Retnakaran is a scholar working on Obstetrics and Gynecology, Endocrinology, Diabetes and Metabolism and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ravi Retnakaran has authored 272 papers receiving a total of 11.7k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Obstetrics and Gynecology, 94 papers in Endocrinology, Diabetes and Metabolism and 85 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ravi Retnakaran's work include Gestational Diabetes Research and Management (128 papers), Pregnancy and preeclampsia studies (82 papers) and Birth, Development, and Health (77 papers). Ravi Retnakaran is often cited by papers focused on Gestational Diabetes Research and Management (128 papers), Pregnancy and preeclampsia studies (82 papers) and Birth, Development, and Health (77 papers). Ravi Retnakaran collaborates with scholars based in Canada, United States and China. Ravi Retnakaran's co-authors include Bernard Zinman, Caroline K. Kramer, Anthony J. Hanley, Philip W. Connelly, Mathew Sermer, Baiju R. Shah, Sara Campbell, Ying Qi, Rury R. Holman and Jill Hamilton and has published in prestigious journals such as The Lancet, Circulation and Nature Communications.

In The Last Decade

Ravi Retnakaran

264 papers receiving 11.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk Factors for Renal Dysfunction in Type 2 Diabetes

2006 731 citations Ravi Retnakaran et al. profile →
Are Metabolically Healthy Overweight and Obesity Benign Conditions?

2013 711 citations Caroline K. Kramer, Bernard Zinman et al. profile →
Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis

2019 596 citations Caroline K. Kramer, Ravi Retnakaran et al. Diabetologia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ravi Retnakaran Canada	55	4.4k	3.7k	2.9k	2.5k	1.7k	272	11.7k
Thomas A. Buchanan United States	45	6.1k 1.4×	3.0k 0.8×	3.4k 1.2×	2.7k 1.1×	1.8k 1.1×	84	11.6k
Thomas A. Buchanan United States	50	3.5k 0.8×	2.8k 0.8×	2.5k 0.9×	1.6k 0.7×	1.0k 0.6×	124	8.8k
Elisabeth R. Mathiesen Denmark	50	5.9k 1.3×	3.8k 1.0×	2.7k 0.9×	2.8k 1.1×	771 0.5×	251	11.1k
Ellen W. Seely United States	58	3.5k 0.8×	2.7k 0.7×	1.1k 0.4×	2.5k 1.0×	736 0.4×	213	9.4k
David R. Hadden United Kingdom	36	3.9k 0.9×	7.6k 2.0×	3.8k 1.3×	1.8k 0.7×	1.3k 0.8×	135	14.0k
Kåre I. Birkeland Norway	52	1.0k 0.2×	4.7k 1.3×	2.3k 0.8×	780 0.3×	2.1k 1.3×	244	10.8k
Berthold Hocher Germany	53	1.0k 0.2×	1.6k 0.4×	1.1k 0.4×	1.6k 0.6×	559 0.3×	355	9.4k
Zhongyan Shan China	50	722 0.2×	6.4k 1.7×	1.0k 0.4×	1.1k 0.4×	1.3k 0.8×	336	11.7k
G. A. Hitman United Kingdom	57	869 0.2×	4.2k 1.1×	5.1k 1.7×	801 0.3×	1.3k 0.8×	245	13.0k
Julie R. Ingelfinger United States	57	928 0.2×	2.2k 0.6×	1.1k 0.4×	1.9k 0.8×	586 0.3×	253	10.6k

Countries citing papers authored by Ravi Retnakaran

Since Specialization

Citations

This map shows the geographic impact of Ravi Retnakaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ravi Retnakaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ravi Retnakaran more than expected).

Fields of papers citing papers by Ravi Retnakaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ravi Retnakaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ravi Retnakaran. The network helps show where Ravi Retnakaran may publish in the future.

Co-authorship network of co-authors of Ravi Retnakaran

This figure shows the co-authorship network connecting the top 25 collaborators of Ravi Retnakaran. A scholar is included among the top collaborators of Ravi Retnakaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ravi Retnakaran. Ravi Retnakaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Retnakaran, Ravi, Dawei Bu, Philip W. Connelly, et al.. (2025). Serum endotrophin relates to blood pressure in young South Asian women but not White women: evidence of ethnic variation in its early vascular implications. BMC Cardiovascular Disorders. 25(1). 689–689.

Levine, Lisa D., et al.. (2025). Subclinical Cardiac Dysfunction in Women With Prior Gestational Diabetes: The Hispanic Community Study/Study of Latinos. Journal of the American Heart Association. 14(20). e042329–e042329.

Richardson, Lisa, et al.. (2024). Representation of racialised and ethnically diverse populations in multicentre randomised controlled trials of GLP-1 medicines for obesity: a systematic review and meta-analysis of gaps. BMJ Global Health. 9(11). e017177–e017177. 3 indexed citations

Semnani‐Azad, Zhila, David E.C. Cole, Betty Wong, et al.. (2024). Urinary Vitamin D Binding Protein: A Marker of Kidney Tubular Dysfunction in Patients at Risk for Type 2 Diabetes. Journal of the Endocrine Society. 8(3). bvae014–bvae014. 2 indexed citations

Retnakaran, Ravi, Chang Ye, Anthony J. Hanley, et al.. (2023). Treatment of Gestational Diabetes Mellitus and Maternal Risk of Diabetes After Pregnancy. Diabetes Care. 46(3). 587–592. 9 indexed citations

Ye, Chang, Anthony J. Hanley, Philip W. Connelly, et al.. (2023). Impact of the diagnosis of gestational diabetes on maternal physical activity after pregnancy. Diabetes Obesity and Metabolism. 26(4). 1207–1215. 1 indexed citations

Retnakaran, Ravi, Chang Ye, Caroline K. Kramer, et al.. (2023). Deteriorating beta cell function is the dominant determinant of progression from normal glucose tolerance to prediabetes/diabetes in young women following pregnancy. Diabetologia. 66(11). 2154–2163. 10 indexed citations

Retnakaran, Ravi, et al.. (2023). The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes. Cardiovascular Diabetology. 22(1). 50–50. 1 indexed citations

Retnakaran, Ravi, et al.. (2023). Future cardiometabolic implications of insulin hypersecretion in response to oral glucose: a prospective cohort study. EClinicalMedicine. 67. 102363–102363. 4 indexed citations

10.

Retnakaran, Ravi, Chang Ye, Anthony J. Hanley, et al.. (2022). Treating Gestational Diabetes Reduces Birth Weight but Does Not Affect Infant Adiposity Across the 1st Year of Life. Diabetes Care. 45(5). 1230–1238. 6 indexed citations

11.

Guo, Yanfang, Daniel J. Corsi, Ruth Rennicks White, et al.. (2022). Folic Acid Supplementation in Early Pregnancy, Homocysteine Concentration, and Risk of Gestational Diabetes Mellitus. Journal of Obstetrics and Gynaecology Canada. 44(2). 196–199. 3 indexed citations

12.

Semnani‐Azad, Zhila, et al.. (2021). Changes in adiposity mediate the associations of diet quality with insulin sensitivity and beta-cell function. Nutrition Metabolism and Cardiovascular Diseases. 31(11). 3054–3063. 3 indexed citations

13.

Retnakaran, Ravi & Bernard Zinman. (2021). The ongoing evolution of basal insulin therapy over 100 years and its promise for the future. Diabetes Obesity and Metabolism. 24(S1). 17–26. 16 indexed citations

14.

Volpe, Alessandro, Ye Rim Chang, Anthony J. Hanley, et al.. (2019). Changes Over Time in Uric Acid in Relation to Changes in Insulin Sensitivity, Beta-Cell Function, and Glycemia. The Journal of Clinical Endocrinology & Metabolism. 105(3). e651–e659. 15 indexed citations

15.

Retnakaran, Ravi, Chang Ye, & Caroline K. Kramer. (2018). Stability of insulin and C‐peptide measurement with long‐term frozen storage of serum: Implications for diabetes research studies. Diabetes Obesity and Metabolism. 21(4). 1058–1060. 4 indexed citations

16.

Kramer, Caroline K., Bernard Zinman, Haysook Choi, Philip W. Connelly, & Ravi Retnakaran. (2017). Chronic liraglutide therapy induces an enhanced endogenous glucagon‐like peptide‐1 secretory response in early type 2 diabetes. Diabetes Obesity and Metabolism. 19(5). 744–748. 15 indexed citations

17.

Harris, Stewart B., Ravi Retnakaran, Adria Giacca, et al.. (2017). Association of NEFA composition with insulin sensitivity and beta cell function in the Prospective Metabolism and Islet Cell Evaluation (PROMISE) cohort. Diabetologia. 61(4). 821–830. 37 indexed citations

18.

Maple‐Brown, Louise, et al.. (2012). Maternal Pregravid Weight Is the Primary Determinant of Serum Leptin and Its Metabolic Associations in Pregnancy, Irrespective of Gestational Glucose Tolerance Status. The Journal of Clinical Endocrinology & Metabolism. 97(11). 4148–4155. 34 indexed citations

19.

Choi, Diana, Stephanie A. Schroer, Shun Lu, et al.. (2010). Erythropoietin protects against diabetes through direct effects on pancreatic β cells. The Journal of Experimental Medicine. 207(13). 2831–2842. 110 indexed citations

20.

Retnakaran, Ravi, Sandy Shen, Anthony J. Hanley, et al.. (2008). Hyperbolic Relationship Between Insulin Secretion and Sensitivity on Oral Glucose Tolerance Test. Obesity. 16(8). 1901–1907. 302 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact